- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- January 2026
- 188 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- January 2026
- 181 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- January 2026
- 180 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- January 2026
- 185 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- January 2026
- 182 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- September 2026
- 182 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 190 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 195 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 197 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 195 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 184 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 193 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 197 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 193 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 181 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 194 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 199 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 184 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more